Philips’ Magnotech to transform global point-of-care testing
Royal Philips Electronics has now developed a unique biosensor technology which has the potential to offer lab-quality immunoassay results at the point of care.
Say something
Tags: Cardiovascular disease, diagnostic tests, Disease, Diseases, Germany, handheld technology, heart attack, Magnotech technology, Marcel van Kasteel, mobile handheld systems, myocardial infarction, Oxford, Philips, Philips Handheld Immunoassays, point of care, Royal Philips Electronics, United Kingdom
-
-
Flipkart Health+ App Launched
06-04-2022
